NM_001374258.1:c.2049A>G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The filtering allele frequency of the c.1929A>G (p.Gly643=) variant in the BRAF gene is 66.117% (6984/10356) of African chromosomes by the Exome Aggregation Consortium, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert Panel (BA1; PMID:29493581) LINK:https://erepo.genome.network/evrepo/ui/classification/CA135110/MONDO:0021060/004

Frequency

Genomes: 𝑓 0.30 ( 10970 hom., cov: 32)
Exomes 𝑓: 0.17 ( 26947 hom. )

Consequence

BRAF
NM_001374258.1 synonymous

Scores

3

Clinical Significance

Benign reviewed by expert panel B:14O:1

Conservation

PhyloP100: 1.58

Publications

32 publications found
Variant links:
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
BRAF Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • cardiofaciocutaneous syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • LEOPARD syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Noonan syndrome 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • Noonan syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • anaplastic astrocytoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001374258.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
NM_001374258.1
MANE Plus Clinical
c.2049A>Gp.Gly683Gly
synonymous
Exon 17 of 20NP_001361187.1A0A2R8Y8E0
BRAF
NM_004333.6
MANE Select
c.1929A>Gp.Gly643Gly
synonymous
Exon 16 of 18NP_004324.2
BRAF
NM_001374244.1
c.2049A>Gp.Gly683Gly
synonymous
Exon 17 of 19NP_001361173.1A0A2U3TZI2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAF
ENST00000644969.2
MANE Plus Clinical
c.2049A>Gp.Gly683Gly
synonymous
Exon 17 of 20ENSP00000496776.1A0A2R8Y8E0
BRAF
ENST00000646891.2
MANE Select
c.1929A>Gp.Gly643Gly
synonymous
Exon 16 of 18ENSP00000493543.1P15056
BRAF
ENST00000288602.11
TSL:1
c.2049A>Gp.Gly683Gly
synonymous
Exon 17 of 19ENSP00000288602.7A0A2U3TZI2

Frequencies

GnomAD3 genomes
AF:
0.301
AC:
45688
AN:
151904
Hom.:
10921
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.669
Gnomad AMI
AF:
0.104
Gnomad AMR
AF:
0.183
Gnomad ASJ
AF:
0.203
Gnomad EAS
AF:
0.175
Gnomad SAS
AF:
0.313
Gnomad FIN
AF:
0.152
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.144
Gnomad OTH
AF:
0.275
GnomAD2 exomes
AF:
0.201
AC:
50505
AN:
250720
AF XY:
0.202
show subpopulations
Gnomad AFR exome
AF:
0.680
Gnomad AMR exome
AF:
0.103
Gnomad ASJ exome
AF:
0.210
Gnomad EAS exome
AF:
0.187
Gnomad FIN exome
AF:
0.149
Gnomad NFE exome
AF:
0.145
Gnomad OTH exome
AF:
0.184
GnomAD4 exome
AF:
0.165
AC:
241653
AN:
1460534
Hom.:
26947
Cov.:
32
AF XY:
0.169
AC XY:
123032
AN XY:
726608
show subpopulations
African (AFR)
AF:
0.686
AC:
22935
AN:
33426
American (AMR)
AF:
0.113
AC:
5058
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.211
AC:
5514
AN:
26092
East Asian (EAS)
AF:
0.156
AC:
6180
AN:
39580
South Asian (SAS)
AF:
0.315
AC:
27154
AN:
86216
European-Finnish (FIN)
AF:
0.143
AC:
7602
AN:
53338
Middle Eastern (MID)
AF:
0.317
AC:
1740
AN:
5492
European-Non Finnish (NFE)
AF:
0.138
AC:
153457
AN:
1111410
Other (OTH)
AF:
0.199
AC:
12013
AN:
60306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
9493
18987
28480
37974
47467
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5818
11636
17454
23272
29090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.301
AC:
45786
AN:
152022
Hom.:
10970
Cov.:
32
AF XY:
0.299
AC XY:
22214
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.669
AC:
27733
AN:
41434
American (AMR)
AF:
0.183
AC:
2796
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.203
AC:
702
AN:
3464
East Asian (EAS)
AF:
0.175
AC:
906
AN:
5168
South Asian (SAS)
AF:
0.312
AC:
1505
AN:
4824
European-Finnish (FIN)
AF:
0.152
AC:
1611
AN:
10592
Middle Eastern (MID)
AF:
0.327
AC:
96
AN:
294
European-Non Finnish (NFE)
AF:
0.144
AC:
9760
AN:
67934
Other (OTH)
AF:
0.276
AC:
582
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1185
2370
3556
4741
5926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
406
812
1218
1624
2030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.221
Hom.:
2667
Bravo
AF:
0.316
Asia WGS
AF:
0.279
AC:
972
AN:
3478
EpiCase
AF:
0.161
EpiControl
AF:
0.162

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
4
RASopathy (4)
-
-
2
not provided (3)
-
-
1
Cardiovascular phenotype (1)
-
-
1
LEOPARD syndrome 3 (1)
-
-
1
Noonan syndrome 7 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_noAF
Benign
-0.49
CADD
Benign
7.9
DANN
Benign
0.74
PhyloP100
1.6
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9648696; hg19: chr7-140449150; COSMIC: COSV56058907; API